Revolutionizing Pediatric Care: The Future of 3D-Printed Bioresorbable Airway Splints
From Emergency Treatment to Mainstream Medicine
For over a decade now, the University of Michigan Health teams have been pioneering the use of 3D-printed bioresorbable airway splints to treat children with the serious condition of tracheobronchomalacia. This condition causes the airway to collapse, making breathing difficult and potentially fatal in severe cases. Infants with this condition often rely on ventilators to survive. The splint was first used in an emergency case in 2012 at the University of Michigan, where the successful rescue of a 3-month-old patient prompted the FDA to grant emergency approval, and the success documented in a New England Journal of Medicine report
The Case for 3D-Printed Biosorbable Devices
Infants face great difficulty with tracheobronchomalacia. Working with a former U-M professor, Scott Hollister, M.D. discovered a biodegradable system that can be 3D-printed to make a tracheal splint customized to the particular patient. The device is affixed to the trachea or the main bronchi and unfolds the airway, keeping it from collapsing. It is capable of developing along with the patient and is eventually absorbed in the body. The clinical trial has now begun.
This initiative marks a critical step toward gaining full FDA approval for broader use of these devices, which have formerly been available only to a limited number of patients through emergency and compassionate use provisions.
| Advantages of 3D-Printed Bioresorbable Airway Splints | |
|---|---|
| Safety and efficacy for those dealing with more serious complications by producing a device to fit that particular patient’s need | Protection from infection. |
| Offers several possibilities in the the clinical and infrastructural realm for improving individuals’ lives. | |
| Physicians can choose from an array of materials and tailor devices to individual needs | Enhances medical professionals adaptability and creativity in solving complicated cases. |
| Promotes Research and Development in current medical technology | Experts have many options for creating treatments and advancing medicine. |
" The technique advancements like 3D printing and cutting-edge visualization techniques have transformed care," said Colleen Wivell Managing Director of Clinical Engineering at Materialise. The initial patient who was treated with this device was a 3-month-old baby who had a dire case. "Surgeons increasingly adopt 3D printing as part of a surgical process to bring personalized care to patients, improving value-based healthcare in the long run, We are thrilled to be contributing to this life-saving treatment and look forward to continuing to support these children and their families." added Wivell
The 8-Year Clinical Trial: A Game-Changer
The groundbreaking trial is designed to answer pivotal questions about the safety and efficacy of these devices, providing a higher level of evidence than previously available through compassionate use cases.
| Key Elements of the Clinical Trial | |
|---|---|
| Duration | 8 years |
| Enrollment Target | 35 infants |
| Participating Hospitals | 5 Institutions: U-M Health C.S. Mott, plus 4 other notable pediatric hospitals across the US. |
| Device Manufacturer | Materialise, a global leader in 3D printing for medical solutions |
| Device | the first 3D implant printed for infants, ES3N Nitinol that also supports the natural growing of the patient’s trachea, and which is easily resorbable into the body. |
Michigan Medicine In conjunction with Materialise, a leading 3D-printing company, Anno Arbor has recently completed the production of these splints. Materialise creates 280,000 custom-made 3D-printed instruments and implants per year, a staggering 160,000 of which are for the U.S. market.
It remains to be seen how well 3D-printing will adapt the functionality of splints and the production rate and whether the FDA will approve them.
Life-Saving Technology: Pioneering Support for Infants
Accurately, the use of the device would also prevent the body from being permanently open as surgical intervention would require precautions to minimize contact with surrounding organs and tissues; It is also critical to understand the risks of not having a functional airway. In the case of an obstruction by scar tissue, an emergency tracheostomy might need to be done to access the airway.
Healthcare technology in the current environment is improving rapidly with these bioprinted systems. However, the transformation of healthcare with bioscience and 3D printing would give promise for the future.
Other institutions are finding fast success in integrating biosafely adaptable to overcome a range of conditions.
The Pathway to Widespread Adoption
There is great hope for this new technique which has a promising outlook but challenge areas exist as well.
There has been successful use of individualized patients with customized caregivers. This allows a dedicated team to create specific treatments for the particular needs of the patient.
The success and results of 3D printing in medicine indicate the future for scientists for advances in health care technology and medical service.
Our CTA:
Join Our Community
Engineers 3D modeling’s success with the airway splint trail is promising and it is a cutting edge biomedical approach. The advent of customized technology such as 3D modeling biosorbable for kids shows promising results delivering lifesaving technology for children’s pulmonary malformations defects or cardiac anomalies. The jury is still out whether surgery-related limitations and having a device varying the patient’s body make it difficult to produce the device for mass manufacturing, despite promising results in the Michigan Medicine Body Busters project. This technology can indeed give hope to concerned parents and families and improve lives in the long run.
FAQ:
What is tracheobronchomalacia?
Tracheobronchomalacia is a rare and sometimes life-threatening condition that causes the airway to collapse. Born infants often rely on ventilators to survive severe cases. The ability to use bioresorbable splints via 3D printing is purported to be an advanced treatment solution for tracheobronchomalacia.
How do 3D-printed bioresorbable airway splints work?
Tracheal splints are attached to the trachea or mainstem bronchi, supporting the airway and preventing collapse. The technology is used for Wi-Fi and photoconductive fabric production and is also used in bioprinting material, which has been used in some medical devices in recent years.
What are the benefits of using 3D-printed bioresorbable airway splints?
The bioresorbable splint is able to safely and naturally absorb into the body while being adaptable to 3D modeling of patients’ cartilaginous tissues which aids in the airway opening technique to prevent it from collapsing.
Would you like to know what questions we should consider in light of the trend on the medical industry potential options previously discussed.
